Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11435-11442

  Srivastava, A K ^a   Singh, P K ^a   Rath, S K ^b   Dalela, D ^a   Goel, M M ^a   Bhatt, M L B ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c DR Ram Manohar Lohia Institute of Medical Sciences Lucknow   (India)

Author keywords

Biomarker; Carcinoma of the urinary bladder; Noninvasive diagnosis; UCA1; Urinary marker; Voided urine cytology

Indexed keywords

LONG UNTRANSLATED RNA; TUMOR MARKER; UCA1 RNA, HUMAN;

ADULT; AGED; BLADDER; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; CYTOLOGY; DISEASE COURSE; FEMALE; FOLLOW UP; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; ROC CURVE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS; URINE;

EID: 84927786047     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2474-z     Document Type: Article

References (15)

1. Agarwal PK, Black PC, Kamat AM. Considerations on the use of diagnostic markers in management of patients with bladder cancer. World J Urol. 2008;26:39–4.
2. Grossfeld GD, Carroll PR. Evaluation of asymptomatic microscopic haematuria. Urol Clin N Am. 1998;25:661–6.
3. Boman H, Hedelin H, Jacobsson S, et al. Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status. J Urol. 2002;168:1955–9.
4. Goebell PJ, Groshen SL, Schmitz-Drager BJ. Guidelines for development of diagnostic markers in bladder cancer. World J Urol. 2008;26:5–11.
5. Justin P, Philippe ES. Current and emerging bladder cancer urinary biomarkers. Sci World J. 2011;11:1103–12.
6. Fan Wang X, Xiao L, Xiea J, et al. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett. 2008;582:1919–27.
7. Jern P, Sperber GO, Ahlsen G, et al. Sequence variability, gene structure, and expression of full-length human endogenous retrovirus H. J Virol. 2005;79:6325–7.
8. Chen Yang X, Li Y, Wang LZ, et al. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene. 2012;496:8–16.
9. Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006;12(16):4851–8.
10. Zhang Z, Hao H, Zhang CJ, et al. Evaluation of novel gene UCA1 as a tumour biomarker for the detection of bladder cancer. Zhonghua Yi Xue Za Zhi. 2012;92(6):384–7.
11. Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley; 2002.
12. Mostofi FK, Sobin LH, Torloni H et al. Histological typing of urinary bladder tumours. World Health Organization Geneva. Volume 10, 1973.
13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25:402–8.
14. Bewick V, Cheek L, Ball J. Statistics review 13: receiver operating characteristic curves. Crit Care. 2004;8:508–12.
15. Srivastava AK, Singh PK, Singh P, et al. Clinical experience with UCA1 as a biomarker for non-muscular invasive bladder cancer. Eur Urol Suppl. 2011;10(2):74.